Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

Journal of Clinical Oncology

Volumn 18, Issue 6, 2000, Pages 1260-1268

  Schmidt, Mary Lou ^a   Lukens, John N ^a   Seeger, Robert C ^a   Brodeur, Garrett M ^a   Shimada, Hiroyuki ^a   Gerbing, Robert B ^a   Stram, Daniel O ^a   Perez, Carlos ^a   Haase, Gerald M ^a   Matthay, Katherine K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

ADOLESCENT; ARTICLE; BONE MARROW CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CHILD; CHILDHOOD CANCER; DNA CONTENT; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0034061843     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.6.1260     Document Type: Article

References (24)

1. Kretschmar CS, Frantz CN, Rosen EM, et al: Improved prognosis for infants with stage IV neuroblastoma. J Clin Oncol 2:799-803, 1984
2. Nickerson HJ, Nesbit ME, Grosfeld JL, et al: Comparison of stage IV and IV-S neuroblastoma in the first year of life. Med Pediatr Oncol 13:261-268, 1985
3. Paul SR, Tarbell NJ, Korf B, et al: Stage IV neuroblastoma in infants: Long-term survival. Cancer 67:1493-1497, 1991
4. Bowman LC, Hancock ML, Santana VM, et al: Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: The St. Jude Children's Research Hospital Experience, 1962 to 1988. J Clin Oncol 9:1599-1608, 1991
5. De Bernardi B, Pianca C, Boni L, et al: Disseminated neuroblastoma (stage IV and IV-S) in the first year of life: Outcome related to age and stage. Cancer 70:1625-1633, 1992
6. Strother D, Shuster JJ, McWilliams N, et al: Results of Pediatric Oncology Group Protocol 8104 for infants with stages D and DS neuroblastoma. J Pediatr Hematol Oncol 17:254-259, 1995
7. De Cou JM, Bowman LC, Rao BN, et al: Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor. J Pediatr Surg 30:937-941, 1995
8. Shorter NA, Davidoff AM, Evans AE, et al: The role of surgery in the management of stage IV neuroblastoma: A single institution study. Med Pediatr Oncol 24:287-291, 1995
9. Hann HWL, Evans AE, Siegel SE, et al: Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: The Childrens Cancer Study Group Experience. Cancer Res 45:2843-2848, 1985
10. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
11. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
12. Seeger RC, Wada R, Brodeur GM, et al: Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 271:41-49, 1988
13. Crabbe DC, Peters J, Seeger RC, et al: Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol 1:229-234, 1992
14. Shimada H, Chatten J, Newton WA, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
15. Chatten J, Shimada H, Sather HN, et al: Prognostic value of histopathology in advanced neuroblastoma: A report from the Childrens Cancer Study Group. Hum Pathol 19:1187-1198, 1988
16. Shimada H, Stram DO, Chatten J, et al: Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 87:1470-1476, 1995
17. Moss TJ, Reynolds CP, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991
18. Look AT, Hayes A, Nitschke R, et al: Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231-235, 1984
19. Look AT, Hayes FA, Schuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group Study. J Clin Oncol 9:581-591, 1991
20. Bowman LC, Castleberry RP, Cantor A, et al: Genetic staging of unresectable metastatic neuroblastoma in infants: A Pediatric Oncology Group Study. J Natl Cancer Inst 89:373-380, 1997
21. Matthay KK, Perez C, Seeger RC, et al: Successful treatment of stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group Study. J Clin Oncol 16:1256-1264, 1998
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
24. Lampert F, Christiansen H, Berner F, et al: Disseminated neuroblastomas under 1 year of age: Cell biology and prognosis. J Neuroncol 31:181-184, 1997